Sign In
Buy AFIB
$0.0001
+0 (+0%)
At Close: Jul 31, 2026
Acutus Medical to Announce Third Quarter 2023 Financial Results
04:13pm, Thursday, 02'nd Nov 2023
CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 02'nd Nov 2023
CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhy
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 02'nd Oct 2023
CARLSBAD, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhy
Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Call Transcript
10:02pm, Monday, 07'th Aug 2023
Acutus Medical, Inc. (NASDAQ:AFIB ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 AM ET Company Participants Caroline Corner - IR David Roman - CEO Takeo Mukai - CFO Conference Call Participant
Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates
06:54pm, Monday, 07'th Aug 2023
Acutus Medical, Inc. (AFIB) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to earnings of $0.16 per share a year ago.
Acutus Medical Reports Second Quarter 2023 Financial Results
04:01pm, Monday, 07'th Aug 2023
CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhy
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Tuesday, 01'st Aug 2023
CARLSBAD, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhy
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
07:00am, Thursday, 27'th Jul 2023
CARLSBAD, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed
Acutus Medical to Announce Second Quarter 2023 Financial Results
04:01pm, Monday, 24'th Jul 2023
CARLSBAD, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Monday, 03'rd Jul 2023
CARLSBAD, Calif., July 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhy
Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Call Transcript
11:38pm, Thursday, 11'th May 2023
Acutus Medical, Inc. (NASDAQ:AFIB ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Caroline Corner - Investor Relations David Roman - President & Chief Executive Officer
Acutus Medical to Announce First Quarter 2023 Financial Results
05:15pm, Friday, 28'th Apr 2023
CARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed
Acutus Medical, Inc. (AFIB) Q4 2022 Earnings Call Transcript
09:12pm, Thursday, 16'th Mar 2023
Start Time: 16:30 January 1, 0000 5:14 PM ET Acutus Medical, Inc. (NASDAQ:AFIB ) Q4 2022 Earnings Conference Call March 16, 2023, 16:30 PM ET Company Participants David Roman - President and CEO Takeo
Acutus Medical, Inc. (AFIB) Q4 Earnings and Revenues Surpass Estimates
07:05pm, Thursday, 16'th Mar 2023
Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 158.57% and 3.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
04:01pm, Thursday, 09'th Mar 2023
CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed
